Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) Director Julie Mchugh sold 22,766 shares of Ironwood Pharmaceuticals stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $6.29, for a total transaction of $143,198.14. Following the transaction, the director now owns 139,528 shares of the company’s stock, valued […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) Director Julie Mchugh sold 22,766 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $6.29, for a total value of $143,198.14. Following the transaction, the director now owns 139,528 shares of the company’s stock, valued […]
Redwood Investment Management LLC lessened its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 14.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 282,619 shares of the biotechnology company’s stock after selling 47,188 shares during the period. Redwood Investment […]
LSV Asset Management lessened its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 5.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 6,782,101 shares of the biotechnology company’s stock after selling 382,108 shares during the period. LSV Asset Management owned 4.34% of Ironwood Pharmaceuticals […]
GW Henssler & Associates Ltd. cut its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 28.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,821 shares of the biotechnology company’s stock after selling 5,500 shares during the quarter. GW Henssler & […]